Mike Sharma @mike_sharma2

Stroke Neurologist McMaster/PHRI Clinical trialist working on stroke prevention Joined December 2013

Tweets

214
Followers

238
Following

329
Likes

289

Christine Hawkes, MD @CMHawkes

2 years ago

Nice work! 🏆 FYI for the trainees, @ArKatsanos started this trial as a STROKE FELLOW @McmasterStroke

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Nice work! 🏆 FYI for the trainees, @ArKatsanos started this trial as a STROKE FELLOW @McmasterStroke

2 11 42 8K 8

Download Image

1 11 37 5K 2

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Interesting data. Quite consistent with our observations in the ANNEXa-I trial. PCC does not seem to provide any benefit in acute FXa inhibitor associated ICH.

Bonaventure Ip @IpBonaventure

2 years ago

Interesting data. Quite consistent with our observations in the ANNEXa-I trial. PCC does not seem to provide any benefit in acute FXa inhibitor associated ICH.

1 23 53 5K 14

0 5 16 3K 5

Mike Sharma @mike_sharma2

2 years ago

Fantastic session - ESUS is evolving more than retiring

Amy Yu, MD @amyyu_md

2 years ago

Fantastic session - ESUS is evolving more than retiring

0 4 23 1K 0

Download Image

0 0 4 238 0

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Excited to join @mike_sharma2, @caso_valeria and @manesh_patelMD at #ISC24 for a dinner symposium on FXIa inhibitors for secondary stroke prevention on Tuesday Feb. 6th. Registration info 👇 Looking forward to seeing you there! @MacDeptMed @AHAScience #stroke #neurotwitter

MedEd On The Go @MedEdOTG

2 years ago

0 3 4 3K 0

Download Image

2 5 16 3K 0

MedEd On The Go @MedEdOTG

2 years ago

Registered for #ISC24 dinner sympo? Factor XI/XIa inhibitors for secondary stroke prevention in pts w/ischemic strokes & TIA risks, 2/6, 6pm MT onsite & online. mededotg.com/ISCfactorXIa @AHAScience @manesh_patelMD @Ash_Shoamanesh @mike_sharma2 @caso_valeria @DukeHeartCenter

0 1 2 202 0

Download Image

Mike Sharma @mike_sharma2

2 years ago

It was a great privilege to be invited to present and meet with the accomplished group at the Cleveland Clinic. Thank you for your hospitality.

Shazam Hussain, MD @shazamhussain

2 years ago

It was a great privilege to be invited to present and meet with the accomplished group at the Cleveland Clinic. Thank you for your hospitality.

1 4 31 4K 0

Download Image

0 1 14 780 0

Mike Sharma @mike_sharma2

2 years ago

It was a great privilege to explore the topic in this setting. Much to be done in this area.

Thomas Meinel @TotoMynell

2 years ago

It was a great privilege to explore the topic in this setting. Much to be done in this area.

0 5 45 3K 2

Download Image

0 0 14 835 0

valeria caso @caso_valeria

2 years ago

WSC 2023 is taking concrete actions to prioritize sustainability and embrace the Sustainable Development Goals (SDGs) principles. One of the most aspects is GOAL 5: Achieve gender equality and empower all women and girls. worldstrokecongress.org/sustainability…

1 7 34 2K 0

Pascal Jabbour MD, FAANS, FACS, FAHA @PascalJabbourMD

2 years ago

Optimal timing to resume anticoagulation after Intracranial Hemorrhage is a controversial topic ! Our latest paper reviewing the topic , definitely in need of a RCT. A shout out to our star research fellow @KareemNaamaniMD @TJUHNeurosurg @TJUHospital journals.lww.com/neurosurgery/f…

1 33 126 23K 24

Download Image

Christian H Nolte @Dr_No_Charite

2 years ago

Delighted to see our most recent paper online. Check out our findings on #cmrt and #holter in #stroke @BerlinStroke @Jan_FriSch #strokeheart #brainheart @ChariteBerlin pubmed.ncbi.nlm.nih.gov/37353342/

1 5 18 3K 2

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Important results for application of Boston Criteria. If trying to identify patients at high risk for future ICH, for instance in relation to risk-benefit of antithrombotic Rx, stick with v1.5 @a_charidimou @BleedingStroke @DavidSeiffge @PrCCordonnier @UCLStrokeRes #neurotwitter

Stroke AHA/ASA @StrokeAHA_ASA

2 years ago

1 30 88 17K 14

Download Image

0 11 35 4K 4

Mike Sharma @mike_sharma2

2 years ago

A pleasure to work with such capable colleagues on this important trial of FXIa inhibition for stroke prevention

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

A pleasure to work with such capable colleagues on this important trial of FXIa inhibition for stroke prevention

0 3 17 1K 0

Download Image

0 0 4 329 0

Mike Sharma @mike_sharma2

2 years ago

Well said - characterizing etiology and prognosis is critical in ICH

David Seiffge @DavidSeiffge

2 years ago

Well said - characterizing etiology and prognosis is critical in ICH

1 4 31 2K 3

0 0 2 179 0

valeria caso @caso_valeria

2 years ago

Yago said that exercise should never stop even if you have too much work and grant applications. To get rid of the burden of work overload and deal better with the toxicity of some people: exercise, exercise, exercise, and have fun. Don't forget October, 1 movement for stroke

2 4 30 2K 0

Download Image

Mike Sharma @mike_sharma2

2 years ago

A new project to uncover the the determinants of post stroke cognitive decline with the talented Raed Joundi.

0 2 17 2K 0

Cheryl Carcel @cheryl_carcel

2 years ago

What a privilege to be on #ESOC2023 TV yesterday talking about diversity and inclusion in clinical trials with the greats @caso_valeria and @mike_sharma2. Moderated by Joanna Wardlaw and Daniel Strbian. Lots of work to do and hoping we can do it together. @ECSandset

0 9 28 2K 0

Download Image

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Very much looking forward to discussing the promising role of FXI(a) inhibition for secondary stroke prevention with @caso_valeria, @mike_sharma2, John Eikelboom and Martin Dichgans at #ESOC2023 this afternoon. @PHRIresearch @McmasterStroke #neurotwitter

0 5 22 957 1

Download Image

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Combining individual participant data from 5 RCTs we demonstrate a high residual risk of recurrent ischemic stroke and all-cause mortality in patients with AF and stroke despite OAC treatment, highlighting a major unmet need in this population. #NeuroTwitter #CardioTwitter

1 19 43 6K 4

Download Image

Ashkan Shoamanesh @Ash_Shoamanesh

2 years ago

Excellent video showing progression of atherosclerotic plaque, fibrous cap disruption, exposure of the lipid core & ensuing thrombosis. Can we identify new therapies that reduce ischemic vascular events without offsetting harm from increased risk of bleeding in these patients?..